Rita de Cassia Ruiz

Dr. Rita de Cassia Ruiz


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 1998 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
RRRita de Cassia Ruiz
Rita de Cassia Ruiz
SFSilvio Favoreto
Silvio Favoreto
LDL. Miriam Dorta
L. Miriam Dorta
EOE. M. Maria Oshiro
E. M. Maria Oshiro
TFT. Alice Ferreira
T. Alice Ferreira
NYNobuko Yoshida
Nobuko Yoshida
Mammalian cell invasion assays, using metacyclic trypomastigotes of Trypanosoma cruzi G and CL strains, showed that the CL strain enters target cells in several-fold higher numbers as compared with the G strain. Analysis of expression of surface glycoproteins in metacyclic forms of the two strains by iodination, immunoprecipitation and FACS, revealed that gp90, undetectable in the CL strain, is one of the major surface molecules in the G strain, that expression of gp82 is comparable in both strains and that gp35/50 is expressed at lower levels in the CL strain. Purified gp90 and gp35/50 bound more efficiently than gp82 to cultured HeLa cells. However, the intensity of the Ca2+ response triggered in HeLa cells by gp82 was significantly higher than that induced by gp35/50 or gp90. Most of the Ca2+ signalling activity of the metacyclic extract towards HeLa cells was due to gp82 and was inhibitable by gp82-specific monoclonal antibody 3F6. Ca2+ mobilization was also triggered in metacyclic trypomastigotes by host-cell components; it was mainly gp82-mediated and more intense in the CL than in the G strain. We propose that expression of gp90 and gp35/50 at high levels impairs binding of metacyclic forms to host cells through productive gp82-mediated interaction, which leads to the target-cell and parasite Ca2+ mobilization required for invasion. Analysis of metacyclic forms of eight additional T. cruzi strains corroborated the inverse correlation between infectivity and expression of gp90 and gp35/50.

1 November 2010 in Vaccine
Verified
Journal Article
Closed access
LCLuciana V. Carvalho
Luciana V. Carvalho
RRRita de Cassia Ruiz
Rita de Cassia Ruiz
KSKarina Scaramuzzi
Karina Scaramuzzi
EMEliana B. Marengo
Eliana B. Marengo
JMJivaldo R. Matos
Jivaldo R. Matos
OSOsvaldo A. Sant’aNna
Osvaldo A. Sant’aNna

16 June 2012 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
ARAlexandre Rodrigues
Alexandre Rodrigues
LPLiu Yu Ping
Liu Yu Ping
PMPriscyla D Marcato
Priscyla D Marcato
OAOswaldo L. Alves
Oswaldo L. Alves
MSMaria C. P. Silva
Maria C. P. Silva
Ana Olívia De SouzaAna Olívia De Souza
Ana Olívia De Souza

1 February 1993 in Parasite Immunology
Verified
Journal Article
Closed access
PDF file
RRRita de Cassia Ruiz
Rita de Cassia Ruiz
VRVera Lucia Rigoni
Vera Lucia Rigoni
JGJorge González
Jorge González
NYNobuko Yoshida
Nobuko Yoshida

1 June 1996 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
FSFabio Rinaldo Santori
Fabio Rinaldo Santori
MDMiriam L. Dorta
Miriam L. Dorta
LJLuiz Juliano
Luiz Juliano
MJMaria A. Juliano
Maria A. Juliano
JSJoséfranco da Silveira
Joséfranco da Silveira
NYNobuko Yoshida
Nobuko Yoshida

1 March 2010 in International Journal of Nanomedicine
Verified
Journal Article
Open access
Lionel F. GamarraLionel F. Gamarra
Lionel F. Gamarra
ADAntonio J Dacosta-Filho
Antonio J Dacosta-Filho
JMJavier Bustamante Mamani
Javier Bustamante Mamani
RRRita de Cassia Ruiz
Rita de Cassia Ruiz
LPLorena F Pavon
Lorena F Pavon
EJEdson Amaro Jr
Edson Amaro Jr
Peer reviewed article authored by (Lionel F Gamarra, Antonio J daCosta-Filho, Javier B Mamani, et al). Read article or submit your manuscript for publishing.